Neurochemical Research

, Volume 18, Issue 5, pp 617–623 | Cite as

Modulation of potassium evoked secretory function in rat cerebellar slices measured by real time monitoring: Evidence of a possible role for methylfolate in cerebral tissue

  • M. D. Lucock
  • M. I. Levene
  • R. Hartley
Original Articles


The real time dynamics of K+ evoked neurosecretion in cerebellar slices has been monitored electrochemically. In the presence of 5-methyltetrahydrofolate a statistically significant diminution in secretory response occurs. Agonists to probe the pharmacological basis for this indicate it is not due to voltage sensitive Ca2+ channel blockade, nor does it show any similarity of effect with kainate, whose receptor is a putative binding site for 5-methyltetrahydrofolate. The method is fully validated, although no account is taken of individual molecular species. High performance liquid chromatography combined with off line microbiological assay could only detect 5-methyltetrahydrofolate in cerebrospinal fluid. We therefore discuss our findings in relation to possible cerebral roles for cerebrospinal fluid 5-methyltetrahydrofolate in the context of both membrane and transmitter related interactions.

Key Words

5-Methyltetrahydrofolate folate kainic acid nifedipine cerebellum cerebrospinal fluid brain real time monitoring 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Melamed, E. 1979. Neurological disorders related to folate deficiency. Pages 423–426in Botez, M. I., and Reynolds, E. H., (eds.), Folic Acid in Neurology, Psychiatry, and Internal Medicine, Raven Press, New York.Google Scholar
  2. 2.
    Turner, A. J. 1983. The fluctuating fortunes of folates. Trends Pharmacol Sci. 4:191–192.Google Scholar
  3. 3.
    Godfrey, P. S. A., Toone, B. K., Carney, M. W. P., Flynn, T. G., Bottiglieri, T., Laundy, M., Chanarin, I., and Reynolds, E. H. 1990. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336:392–395.PubMedGoogle Scholar
  4. 4.
    Reynolds, E. H., Carney, M. W. P., and Toone, B. K. 1984 Methylation and Mood. Lancet ii:196–198.Google Scholar
  5. 5.
    Reynolds, E. H. 1976. Neurological aspects of folate and vitamin B12 metabolism. Pages 661–696in Hoffbrand, A. V. (ed) Clinics in Haematology, Vol 5, W. B. Saunders, Philadelphia.Google Scholar
  6. 6.
    Smith, D. B., and Obbens, E. A. M. T. 1979. Antifolate-antiepileptic relationships. Pages 267–283in Botez, M. I. and Reynolds, E. H. (eds). Folic acid in Neurology, Psychiatry and Internal Medicine, Raven Press, New York.Google Scholar
  7. 7.
    Clifford, D. B., and Ferrendelli, J. A. 1983. Neurophysiologic effects of folate compounds in hippocampus in vitro. Brain Res. 266:209–216.PubMedGoogle Scholar
  8. 8.
    Hommes, O.R., and Obbens, E. A. M. T. 1972. The epileptogenic action of Na folate in the rat. J. Neurol. Sci. 16:271–281.PubMedGoogle Scholar
  9. 9.
    Noëll, W. K., Magoss, M. S., Cohen, L. H., Mollant, J. F., and Walters, G. G. 1960. Cerebral effects of folic acid, pyrimidines, amino acids, and their antimetabolites. Electroenceph. Clin. Neurophysiol. 12:238.Google Scholar
  10. 10.
    Spector, R. G. 1971. Folic acid and convulsions in the rat. Biochem. Pharmacol. 20:1730–1732.Google Scholar
  11. 11.
    Roberts, P. J. 1974. Inhibition of high-affinity glial uptake of14C-glutamate by folate. Nature 250:429–430.PubMedGoogle Scholar
  12. 12.
    Hill, R. G., and Miller, A. A. 1974. Antagonism by folic acid of presynaptic inhibition in the rat cuneate nucleus. Br. J. Pharmacol. 50:425–427.PubMedGoogle Scholar
  13. 13.
    Tunniclife, G., and Ngo, T. T. 1977. Folic acid and the inhibition of brainl-glutamic decarboxylase. Experentia 33:67–68.Google Scholar
  14. 14.
    Ruck, A., Kramer, S., Metz, J., and Brennan, M. J. W. 1980 Methyltetrahydrofolate is a potent and selective agonist for kainic acid receptors. Nature 287:852–853.PubMedGoogle Scholar
  15. 15.
    Olney, J. W., Fuller, T. A., and Gubareff, T. 1981. Kainate like neurotoxicity of folates. Nature 292:165–167.PubMedGoogle Scholar
  16. 16.
    Brennan, M. J. W., Fernandes-Costa, F., Metz, J., Kramer, S., and Scriven, D. R. L. 1981. Depolarisation-induced release of folates from slices of rat cerebellum. Neurosci. Lett. 27:347–350.PubMedGoogle Scholar
  17. 17.
    Janssens, P. M., and Van Haastert, P. J. 1987. Molecular basis of transmembrane signal transduction in dictyostelium discoideum. Microbiol. Rev. 51:396–418.PubMedGoogle Scholar
  18. 18.
    Harley, D. M., and Snodgrass, S. R. 1990. Folate interactions with cerebral G proteins. Neurochem. Res. 15:681–686.PubMedGoogle Scholar
  19. 19.
    Spector, R. 1979 Cerebrospinal fluid folate and the blood brain barrier. Pages 187–194in Botez, M. I. and Reynolds, E. H. (eds). Folic Acid in Neurology, Psychiatry and Internal Medicine, Raven Press, New York.Google Scholar
  20. 20.
    Korevaar, W. C., Geyer, M. A., Knapp, S., Hsu, L. L., and Mandell, A. J. 1973. Regional distribution of 5-methyltetrahydrofolic acid in brain. Nature (New Biol) 245:244–245.Google Scholar
  21. 21.
    McClain, L. D., Carl, G. F., and Bridgers, W. F. 1975. Distribution of folic acid coenzymes and folate dependent enzymes in mouse brain. J. Neurochem. 24:719–722.PubMedGoogle Scholar
  22. 22.
    Kataoka, Y., Kuizumi, S., Kumakura, K., Kurihara M., Niwa, M., and Ueki, S. 1989. Endothelin-triggered brain danage under hypoglycaemia evidenced by real-time monitoring of dopamine release from rat striatal slices Neurosci. Lett. 107:75–80.PubMedGoogle Scholar
  23. 23.
    Takei, N., Tsukui, H., Kumakura, K., and Hatanaka, H. 1990 Monitoring of acetylcholine released from post natal rat basal forebrain cholinergic neurons cultured on membrane filter by cell bed perfusion system and HPLC-ECD. Exp. Neurol. 108:229–231.PubMedGoogle Scholar
  24. 24.
    Kamakura, K., Ohara, M., and Sato, G. P., 1986. Real-time monitoring of the secretory function of cultured adrenal chromaffin cells. J. Neurochem. 46:1851–1858.PubMedGoogle Scholar
  25. 25.
    Kataoka, Y., Imaizumi, M. O., Ueki, S., and Kumakura, K. 1988. Stimulatory action of gamma-aminobutyric acid on catecholamine secretion from bovine adrenal chromaffin cells measured by a real-time monitoring system. J. Neurochem. 50:1765–1768.PubMedGoogle Scholar
  26. 26.
    Lucock, M. D., Hartley, R., and Smithells, R. W., 1989. A rapid and specific HPLC-electrochemical method for the determination of endogenous 5-methyltetrahydrofolic acid in plasma using solid phase sample preparation with internal standardization. J. Biomed. Chromatogr. 3:58–63.Google Scholar
  27. 27.
    Lucock, M. D., Wild, J., Smithells, R. W., and Hartley, R. 1989 In vivo characterisation of the absorption and biotransformation of pteroylmonoglutamic acid in man: A model for future studies. Biochem. Med. Metab. Biol. 42:30–42.PubMedGoogle Scholar
  28. 28.
    Choi, D. W. 1988. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischaemic damage. Trends Neurosci. 11:465–469.PubMedGoogle Scholar
  29. 29.
    Wang, K. T., Andrews, H., and Thukral, V. 1992. Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals. J. Neurochem. 58:204–211.PubMedGoogle Scholar
  30. 30.
    Brennan, M. J. W., Cantrill, R. C., Warner, S. J. C., Van der Westhuyzen, J., Fernandes-Costa, F., Kramer, S., and Metz, J. 1981. Amino acid transmitter receptor binding in synaptic membranes from normal and vitamin B12 deficient fruit bats. Brain Res. 219:186–189.PubMedGoogle Scholar
  31. 31.
    Foster, A. C., and Roberts, P. J. 1980. Morphological and biochemical changes in the cerebellum induced by kainic acid in vivo. J. Neurochem. 34:1991–1200.Google Scholar
  32. 32.
    Herndon, R. M., and Coyle, J. T. 1978. Glutamatergic innervation, kainic acid and selective vulnerability in the cerebellum. Pages 189–200in McGeer, E. G., Olney, J. W., and McGeer, P. L. (eds). Kainic Acid as a Tool in Neurobiology, Raven Press, New York.Google Scholar
  33. 33.
    Stryer, L., and Bourne, H. R. 1986. G proteins: A family of signal transducers. Ann. Rev. Cell Biol. 2:391–419.PubMedGoogle Scholar
  34. 34.
    Osmond, H., and Smythies, J. R. 1952. Schizophrenia a new approach. J. Ment. Sci. 98:309–315.PubMedGoogle Scholar
  35. 35.
    Botez, M. I., Young, S. N., Bachevalier, J., and Gauthier, S. 1979. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature (Lond) 278:182–183.Google Scholar
  36. 36.
    Botez, M. I., Young, S. N., Bachevalier, J., and Gauthier, S. 1982. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann. Neurol. 12:479–484.PubMedGoogle Scholar
  37. 37.
    Lucock, M. D., Wild, J., Hartley, R. Levene, M. I., and Schorah, C. J. 1991. Vitamins to prevent neural tube defects. Lancet 338:894–895.Google Scholar
  38. 38.
    Spector, R. 1977. Vitamin homeostasis in the CNS. N Engl. J. Med. 296:1393–1398.PubMedGoogle Scholar
  39. 39.
    Mattson, R. H., Gallagher, B. B., Reynolds, E. H., and Glass, D. 1973. Folate therapy in epilepsy. Arch. Neurol. 29:78–81.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • M. D. Lucock
    • 1
  • M. I. Levene
    • 1
  • R. Hartley
    • 1
  1. 1.Aeademic Unit of Paediatrics, Department of Clinical Medicine, D Floor, Clarendon Wing, The General Infirmary at LeedsUniversity of LeedsLeedsUK

Personalised recommendations